What is the official website of MSD South Africa ?

The official website of MSD South Africa is http://www.msd.co.za.

What is MSD South Africa's cybersecurity risk score?

MSD South Africa has an AI-generated cybersecurity risk score of 753 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has MSD South Africa experienced?

According to Rankiteo, MSD South Africa currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has MSD South Africa been affected by any supply chain cyber incidents ?

According to Rankiteo, MSD South Africa has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does MSD South Africa have SOC 2 Type 1 certification ?

According to Rankiteo, MSD South Africa is not certified under SOC 2 Type 1.

Does MSD South Africa have SOC 2 Type 2 certification ?

According to Rankiteo, MSD South Africa does not hold a SOC 2 Type 2 certification.

Does MSD South Africa comply with GDPR ?

According to Rankiteo, MSD South Africa is not listed as GDPR compliant.

Does MSD South Africa have PCI DSS certification ?

According to Rankiteo, MSD South Africa does not currently maintain PCI DSS compliance.

Does MSD South Africa comply with HIPAA ?

According to Rankiteo, MSD South Africa is not compliant with HIPAA regulations.

Does MSD South Africa have ISO 27001 certification ?

According to Rankiteo,MSD South Africa is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does MSD South Africa operate in ?

MSD South Africa operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does MSD South Africa have ?

MSD South Africa employs approximately 177 people worldwide.

Does MSD South Africa own any subsidiaries ?

MSD South Africa presently has no subsidiaries across any sectors.

How many LinkedIn followers does MSD South Africa have ?

MSD South Africa's official LinkedIn profile has approximately 18,332 followers.

What is the NAICS classification code for MSD South Africa ?

MSD South Africa is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does MSD South Africa have a Crunchbase profile ?

No, MSD South Africa does not have a profile on Crunchbase.

Does MSD South Africa have a LinkedIn profile ?

Yes, MSD South Africa maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/msdsouthafrica.

How many cybersecurity incidents has MSD South Africa experienced ?

As of September 24, 2026, Rankiteo reports that MSD South Africa has experienced 1 cybersecurity incidents.

How many peer or competitor companies does MSD South Africa have ?

MSD South Africa has an estimated 5,769 peer or competitor companies worldwide.

What types of cybersecurity incidents has MSD South Africa faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

MSA

Boost Score +25 with badge (5 left)

753

/1000

Fair

778

/1000

Fair

MSD South Africa Vendor Cyber Rating & Cyber Score

msd.co.za

Add Your Compliance Badge

We are inspired by the difference we can make in the lives of people around the world through the innovative medicines, vaccines, and consumer health and animal products we discover and produce. Our products cover a broad range of areas, including heart and respiratory health, infectious diseases, sun care and women's health. And we focus our research on conditions that affect millions of people around the world - diseases like Alzheimer's, diabetes and cancer - while building strengths in new areas like biologics. While we work to develop innovative therapies, we also work hard to make sure they're affordable. That's why we offer assistance and discount programs to help make our medicines accessible to those who need them. At today's

MSA

MSD South Africa CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

MSD South Africa

Breach

9/2025

MSD060270611182...

Loading…

A.I.

MSA Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for MSA

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MSD South Africa in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for MSD South Africa in 2026.

Incident Types MSA vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MSD South Africa in 2026.

Incident History - MSA (X = Date, Y = Severity)

Loading…

SUBSIDIARY

MSD South Africa Subsidiaries

MSA

Pharmaceutical Manufacturing

Website: http://www.msd.co.za

Company Size: 177

MSDPharmaceutical Manufacturing

MSD Saúde AnimalVeterinary Services

MSD Animal HealthPharmaceutical Manufacturing

MSD LATAMPharmaceutical Manufacturing

MSD EspañaPharmaceutical Manufacturing

MSD EgyptPharmaceutical Manufacturing

MSD DeutschlandPharmaceutical Manufacturing

MSD FrancePharmaceutical Manufacturing

MSD NetherlandsPharmaceutical Manufacturing

MSD GCCPharmaceutical Manufacturing

MSD SwitzerlandPharmaceutical Manufacturing

MSD in the UKPharmaceutical Manufacturing

MSD ItaliaPharmaceutical Manufacturing

MSD Animal Health Technology LabsTechnology, Information and Internet

MSD Australia & New ZealandPharmaceutical Manufacturing

MSD TürkiyePharmaceutical Manufacturing

MSD GreecePharmaceutical Manufacturing

MSD PortugalPharmaceutical Manufacturing

MSD JordanPharmaceutical Manufacturing

MSD Czech RepublicPharmaceutical Manufacturing

MSD PolskaPharmaceutical Manufacturing

MSD ÖsterreichPharmaceutical Manufacturing

MSD BelgiumPharmaceutical Manufacturing

MSD LebanonPharmaceutical Manufacturing

MSD SverigePharmaceutical Manufacturing

MSD RomaniaPharmaceutical Manufacturing

MSD SRBIJAPharmaceutical Manufacturing

MSD MagyarországPharmaceutical Manufacturing

MSD DanmarkPharmaceutical Manufacturing

MSD Animal Health UK LtdPharmaceutical Manufacturing

MSD FinlandPharmaceutical Manufacturing

MSD NorgePharmaceutical Manufacturing

MSD SlovenskoPharmaceutical Manufacturing

MSD UkrainePharmaceutical Manufacturing

Loading…

MSD South Africa Similar Companies

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Cipla

cipla.com

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

Sanofi

sanofi.com

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

Novo Nordisk

cb novonordisk.com

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

Lupin

lupin.com

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

Dr. Reddy's Laboratories

drreddys.com

Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ

Lonza

lonza.com

Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Founded in Switzerland in 1897, our company is the first and original CDMO, and today we are more dynamic, agile and forward-focused than ever before. As one of the largest Western CDMOs, we bring together a global team of around 18,500 colleagues across five continents to deliver comprehensive, integrated solutions for our customers' complex needs. For our customers and their patients, we bring quality, safety and reliability to bring life-enhancing and life-saving treatments to market at speed and at scale. For our colleagues, we strive to create a sense of belonging and inclusion where every person can thrive and bring their best.

Loading…

NEWS

MSD South Africa CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

February 12, 2024 08:00 AM

SANDF opens 2025 MSDS applications

The South African National Defence Force (SANDF) has opened its Military Skills Development System (MSDS) applications for 2025,...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-96680

SUMMARY

A vulnerability was detected in ByteDance Coze Scraper Extension up to 2.0.2. Affected by this vulnerability is the function chrome.runtime.onMessageExternal.addListener of the file static/background/index.js of the component External Message Handler. The manipulation of the argument body.url/paginationConfig/xPathConfig/body.urls/xPaths results in missing authorization. The attack can be launched remotely. The exploit is now public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-23

Updated

Date2026-09-23

RISK INFORMATION (Score: 4.3)

cvss2

Base Score: 5.0

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:N/A:N

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:N/A:N

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.8

REFERENCES

CVE-2026-96678

SUMMARY

A security vulnerability has been detected in weiqingwen spring-boot-forum up to 538eecc3c6b85fdf0768ab4e8354b48c0c17d94f. Affected is the function validate of the file src/main/java/com/qingwenwei/util/NewUserFormValidator.java of the component Avatar Upload. The manipulation of the argument Username leads to path traversal. The attack can be initiated remotely. The exploit has been disclosed publicly and may be used. Continious delivery with rolling releases is used by this product. Therefore, no version details of affected nor updated releases are available. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-23

Updated

Date2026-09-23

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-96676

SUMMARY

A vulnerability was identified in Fast FAC1900R 20190827_2.0.2. The impacted element is the function get_alias_name of the component uhttpd. Such manipulation leads to stack-based buffer overflow. The attack may be performed from remote. The exploit is publicly available and might be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-23

Updated

Date2026-09-23

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-96606

SUMMARY

A security flaw has been discovered in LB-Link BL-CPE600EU 5.8.13. This vulnerability affects unknown code of the file Mifi_config.bin of the component Configuration Backup Handler. The manipulation results in information disclosure. The attack can be launched remotely. The exploit has been released to the public and may be used for attacks. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-23

Updated

Date2026-09-23

RISK INFORMATION (Score: 5.3)

cvss2

Base Score: 5.0

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:N/A:N

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

3.9

REFERENCES

CVE-2026-70125

SUMMARY

Microsoft Outlook Remote Code Execution Vulnerability

Published

Date2026-09-23

Updated

Date2026-09-23

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

2.8

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-70125

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

MSD South Africa Vendor Cyber Rating & Cyber Score

MSA A.I CyberSecurity Scoring

MSD South Africa CyberSecurity News & History

MSA Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for MSA

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types MSA vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - MSA (X = Date, Y = Severity)

MSD South Africa Subsidiaries

MSA

MSD South Africa Similar Companies

Teva Pharmaceuticals

Cipla

Sanofi

Novo Nordisk

Sandoz

Lupin

Takeda

Dr. Reddy's Laboratories

Lonza

MSD South Africa CyberSecurity News

SANDF opens 2025 MSDS applications

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

MSD South Africa CyberSecurity News & History

MSA Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for MSA

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types MSA vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - MSA (X = Date, Y = Severity)

MSD South Africa Subsidiaries

MSA

MSD South Africa Similar Companies

Teva Pharmaceuticals

Cipla

Sanofi

Novo Nordisk

Sandoz

Lupin

Takeda

Dr. Reddy's Laboratories

Lonza

MSD South Africa CyberSecurity News

SANDF opens 2025 MSDS applications

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo